Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2019 07:52 ET | Source: BioSig Technologies, Inc.

BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address...
April 12, 2017 06:30 ET | Source: Neuronascent, Inc.

Neuronascent Appoints New Board Member

CLARKSVILLE, MD--(Marketwired - April 12, 2017) - Neuronascent, Inc., a neuro-pharmaceutical company developing proprietary therapeutics for Alzheimer's disease, Parkinson's disease, and psychiatric...
January 29, 2014 07:00 ET | Source: Neuronascent, Inc.

Neuronascent, Inc. Announces Issuance of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate

CLARKSVILLE, MD--(Marketwired - Jan 29, 2014) - Neuronascent, Inc. announced today the issuance of the United States patent covering a new compound family that includes Neuronascent's lead...
June 25, 2013 12:39 ET | Source: Neuronascent, Inc.

Neuronascent, Inc. Announces Issuance of Canadian Patent Covering Its Lead Alzheimer's Disease Candidate

CLARKSVILLE, MD--(Marketwired - Jun 25, 2013) - Neuronascent, Inc. announced today the issuance of a Canadian patent covering its compound families that include Neuronascent's Alzheimer's...